BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jaiswal A, Nguyen VQ, Le Jemtel TH, Ferdinand KC. Novel role of phosphodiesterase inhibitors in the management of end-stage heart failure. World J Cardiol 2016; 8(7): 401-412 [PMID: 27468333 DOI: 10.4330/wjc.v8.i7.401]
URL: https://www.wjgnet.com/1949-8462/full/v8/i7/401.htm
Number Citing Articles
1
Archana G. Venakatesh, Johann J. Mathew, Scott Coleman, Longqiu Yang, Geoffrey L. Liu, Marilyn M. Li, Henry Liu. Effects of milrinone on inflammatory response-related gene expressions in cultured rat cardiomyocytesThe Journal of Biomedical Research 2019; 33(4): 258 doi: 10.7555/JBR.32.20170085
2
Gaspar Del Rio-Pertuz, Juthipong Benjanuwattra, Phichayut Phinyo, Natnicha Leelaviwat, Poemlarp Mekraksakit, Nandini Nair. The Mortality Benefit of Milrinone as a Continuous Outpatient Intravenous Inotrope Therapy in Advanced Heart Failure: A Systemic Review and Meta-AnalysisInternational Journal of Heart Failure 2023; 5(2): 106 doi: 10.36628/ijhf.2022.0034
3
Nadja I. Bork, Cristina E. Molina, Viacheslav O. Nikolaev. cGMP signalling in cardiomyocyte microdomainsBiochemical Society Transactions 2019; 47(5): 1327 doi: 10.1042/BST20190225
4
Sarah Chuzi, Larry A. Allen, Shannon M. Dunlay, Haider J. Warraich. Palliative Inotrope TherapyJAMA Cardiology 2019; 4(8): 815 doi: 10.1001/jamacardio.2019.2081
5
Eva M. Wu, Tarek Y. El Ahmadieh, Benjamin Kafka, Matthew T. Davies, Salah G. Aoun, Jonathan A. White. Milrinone-Associated Cardiomyopathy and Arrhythmia in Cerebral VasospasmWorld Neurosurgery 2018; 114: 252 doi: 10.1016/j.wneu.2018.03.151